Clinical trial
Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of…
NCT00240747 · Pfizer, Industry · Terminated
Key facts
| NCT number | NCT00240747 |
|---|---|
| Title | Open-label, Multiple-dose, Phase III Study of the Population Pharmacokinetics of I.V. Synercid in 75 Pediatric Patients |
| Lead sponsor | Pfizer, Industry |
| Collaborators | Aventis Pharmaceuticals Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gram-Positive Bacterial Infections |
| Intervention type | Drug |
| Interventions | Synercid |
| Start date | Jun 1, 2000 |
| Completion | Jan 1, 2005 |
| First posted | Oct 18, 2005 |
| Last update posted | May 25, 2012 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: